Fusion Pharm Stock Price on September 27, 2024
| FSPM Stock | USD 0.0001 0.00 0.00% |
Below is the normalized historical share price chart for Fusion Pharm extending back to July 17, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fusion Pharm stands at 0.0001, as last reported on the 25th of November, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in Fusion Stock, it is important to understand the factors that can impact its price. We have found three technical indicators for Fusion Pharm, which you can use to evaluate the volatility of the firm.
As of the 25th of November 2024, Sale Purchase Of Stock is likely to grow to about 98.3 K, while Total Stockholder Equity is likely to drop (2.6 K). . Fusion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta 9.72 |
Fusion |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| FSPM |
Based on monthly moving average Fusion Pharm is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fusion Pharm by adding Fusion Pharm to a well-diversified portfolio.
Book Value (0.07) | Enterprise Value 294.4 K | Price Sales 0.0032 | Shares Outstanding 10.6 M | Market Capitalization 1.1 K |
Fusion Pharm Valuation on September 27, 2024
It is possible to determine the worth of Fusion Pharm on a given historical date. On September 27, 2024 Fusion was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fusion Pharm stock. Still, in general, we apply an absolute valuation method to find Fusion Pharm's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fusion Pharm where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fusion Pharm's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/27/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Fusion Pharm | | | Fusion Pharm History | | | Fusion Pharm Valuation | Previous | Next |
Fusion Pharm Trading Date Momentum on September 27, 2024
| On September 30 2024 Fusion Pharm was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on September 30, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Fusion Pharm Fundamentals Correlations and Trends
By evaluating Fusion Pharm's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fusion Pharm's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fusion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fusion Pharm Stock history
Fusion Pharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fusion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fusion Pharm will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fusion Pharm stock prices may prove useful in developing a viable investing in Fusion Pharm
| Last Reported | Projected for Next Year | ||
| Net Loss | -37.9 K | -36 K |
Fusion Pharm Stock Technical Analysis
Fusion Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Fusion Pharm Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Fusion Pharm cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fusion Pharm November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Fusion Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharm shares will generate the highest return on investment. By undertsting and applying Fusion Pharm stock market strength indicators, traders can identify Fusion Pharm entry and exit signals to maximize returns
When determining whether Fusion Pharm is a strong investment it is important to analyze Fusion Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fusion Pharm's future performance. For an informed investment choice regarding Fusion Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.